Efficacy versus effectiveness of octreotide in the prophylaxis of post-ERCP pancreatitis [1]

American Journal of Gastroenterology

Volumn 102, Issue 7, 2007, Pages 1539-

  Andriulli, Angelo ^a   Loperfido, Silvano ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; LETTER; MAJOR CLINICAL STUDY; PANCREAS INJURY; PANCREATITIS; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

BILE DUCT DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; GASTROINTESTINAL AGENTS; HUMANS; OCTREOTIDE; PANCREATITIS; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 34250881182     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01328.x     Document Type: Letter

References (4)

1. Li ZS, Pan X, Zhang WJ, et al. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol 2007 102 : 46 51.
2. Andriulli A, Leandro G, Niro G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: A meta-analysis. Gastrointest Endosc 2000 51 : 1 7.
3. Testoni PA, Bagnolo F, Andriulli A, et al. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: Results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther 2001 15 : 965 72.
4. Andriulli A, Loperfido S, Napoletano G, et al. Incidence rates of post-ERCP complications. A systematic survey of prospective studies. Am J Gastroenterol 2007 in press ].